Try our mobile app
Screener

Reviews

2026-09-14
#reports #MSEX

[Middlesex Water](https://eninvs.com/all.php?name=MSEX) (Water supply company) reported for 2026 q1
(2026-07-24, After Market Close):

- Revenue +27.3% YoY (vs +4.3% in previous quarter and historical rate +8.5%)
- EBITDA +31.6% YoY (vs +16.7% in previous quarter and historical rate +11.9%)
- EBITDA margin 44.6% increased compared to 43.2% same period last year
- Net Debt increased by $24 mln over the past reporting period (2.4% of market cap)
- FCF (LTM) -$0.1 bln (negative), 5.4% of market cap
- EV/EBITDA multiple is 15.4x compared to historical level (75th percentile) of 18.7x
- EV/Sales multiple is 6.8x

2026-09-14
#reports #MSCI

[MSCI](https://eninvs.com/all.php?name=MSCI) (Finance company) reported for 2026 q1
(2026-04-21, Before Market Open):

- Revenue +12.2% YoY (vs +14.1% in previous quarter and historical rate +20.9%)
- Net Income +12.5% YoY (vs +40.5% in previous quarter and historical rate +21.5%)
- Net Income margin 39.4% increased compared to 39.3% same period last year
- P/E multiple is 30.7x compared to historical level (75th percentile) of 40.2x
- P/S multiple is 12.4x
- Price to book: -15.6x

2026-09-14
#reports #MSB

[Mesabi Trust](https://eninvs.com/all.php?name=MSB) (Steel) reported for 2026 q1
(2025-12-12, After Market Close):

- Revenue -60% YoY (vs -85.7% in previous quarter and historical rate +33.4%)
- EBITDA -100% YoY (vs -92.9% in previous quarter and historical rate +33.9%)
- EV/EBITDA multiple is 32.7x compared to historical level (75th percentile) of 4.8x
- EV/Sales multiple is 21.3x

At the opening of the session the share price went down -0.9%
2026-09-14
#reports #MRAI

[Marpai, Inc.](https://eninvs.com/all.php?name=MRAI) (Healthcare Plans) reported for 2026 q1
(2026-03-25, After Market Close):

- Revenue -20% YoY (vs -20.0% in previous quarter and historical rate -10.1%)
- Net Income margin -75.0% increased compared to -80.0% same period last year
- P/S multiple is 4.8x
- Price to book: -2.3x

2026-09-14
#reports #MQ

[Marqeta, Inc.](https://eninvs.com/all.php?name=MQ) (Software — Infrastructure) reported for 2026 q1
(2026-05-05, After Market Close):

- Revenue +17.3% YoY (vs +19.4% in previous quarter and historical rate -1.4%)
- EBITDA margin 7.4% increased compared to -2.0% same period last year
- EV/EBITDA multiple is 193x compared to historical level (75th percentile) of 1213x
- EV/Sales multiple is 9.7x

2026-09-14
#reports #MOH

[Molina Healthcare](https://eninvs.com/all.php?name=MOH) (Health care provider) reported for 2026 q1
(2026-04-22, After Market Close):

- Revenue -4.8% YoY (vs -3.1% in previous quarter and historical rate +11.2%)
- Net Income -76.5% YoY (vs -95.3% in previous quarter and historical rate -15.0%)
- Net Income margin 0.6% decreased compared to 2.2% same period last year
- P/S multiple is 0.3x
- Price to book: 2.9x

2026-09-14
#reports #MNKD

[MannKind Corporation](https://eninvs.com/all.php?name=MNKD) (Biotechnology) reported for [2026 q1](https://eninvs.com/press_release.php?ticker=MNKD&q=2026 q1&id=944192)
(2026-05-06, After Market Close):

- Revenue +41.6% YoY (vs +15.4% in previous quarter and historical rate +36.5%)
- EBITDA -14.3% YoY (vs -79.2% in previous quarter and historical rate +82.6%)
- EBITDA margin 5.5% decreased compared to 9.1% same period last year
- EV/EBITDA multiple is 42.5x compared to historical level (75th percentile) of 34.1x
- EV/Sales multiple is 2.9x

2026-09-14
#reports #MMSI

[Merit Medical Systems](https://eninvs.com/all.php?name=MMSI) (Medical instrument manufacturer) reported for 2026 q1
(2026-02-24, After Market Close):

- Revenue +9.7% YoY (vs +7.6% in previous quarter and historical rate +9.7%)
- EBITDA +16.7% YoY (vs +7.1% in previous quarter and historical rate +27.6%)
- EBITDA margin 21.7% increased compared to 20.4% same period last year
- Net Debt increased by $38 mln over the past reporting period (0.7% of market cap)
- FCF (LTM) +$0.1 bln (positive), 2.1% of market cap
- EV/EBITDA multiple is 17x compared to historical level (75th percentile) of 22.7x
- EV/Sales multiple is 3.5x

2026-09-14
#reports #MMI

[Marcus & Millichap](https://eninvs.com/all.php?name=MMI) (Investment brokerage company) reported for 2026 q1
(2026-05-07, Before Market Open):

- Revenue +18% YoY (vs +17.9% in previous quarter and historical rate +1.3%)
- EBITDA margin 2.5% increased compared to -3.5% same period last year
- EV/EBITDA multiple is 58.4x compared to historical level (75th percentile) of 35.9x
- EV/Sales multiple is 1.4x

2026-09-14
#reports #MLI

[Mueller Industries](https://eninvs.com/all.php?name=MLI) (Pipelines and components manufacturer) reported for 2026 q1
(2026-04-28, Before Market Open):

- Revenue +42.8% YoY (vs +29.1% in previous quarter and historical rate +8.9%)
- EBITDA +46.6% YoY (vs +71.4% in previous quarter and historical rate +14.6%)
- EBITDA margin 22.9% increased compared to 22.3% same period last year
- Net Debt decreased by $1.4 bln since the start of the year (20.6% of market cap)
- FCF (LTM) +$0.7 bln (positive), 10.4% of market cap
- EV/EBITDA multiple is 4.2x compared to historical level (75th percentile) of 12.7x
- EV/Sales multiple is 1.1x

2026-09-14
#reports #MKTX

[MarketAxess](https://eninvs.com/all.php?name=MKTX) (Bond trading platform) reported for [2026 q1](https://eninvs.com/press_release.php?ticker=MKTX&q=2026 q1&id=942094)
(2026-07-22, Before Market Open):

- Revenue +4.3% YoY (vs +15.3% in previous quarter and historical rate +6.4%)
- Net Income +353.3% YoY (vs +20.0% in previous quarter and historical rate +11.9%)
- Net Income margin 31.2% increased compared to 7.2% same period last year
- P/E multiple is 21.5x compared to historical level (75th percentile) of 32.4x
- P/S multiple is 7x
- Price to book: 5.3x

2026-09-14
#reports #MKSI

[MKS Instruments](https://eninvs.com/all.php?name=MKSI) (Gas monitoring and analysis instruments supplier) reported for [2026 q1](https://eninvs.com/press_release.php?ticker=MKSI&q=2026 q1&id=944189)
(2026-04-28, After Market Close):

- Revenue +28.3% YoY (vs +15.2% in previous quarter and historical rate +5.0%)
- EBITDA +50.7% YoY (vs +19.4% in previous quarter and historical rate +40.4%)
- EBITDA margin 26.9% increased compared to 22.9% same period last year
- EV/EBITDA multiple is 18.1x compared to historical level (75th percentile) of 21.3x
- EV/Sales multiple is 4.3x

2026-09-14
#reports #MKC-V

[McCormick & Company](https://eninvs.com/all.php?name=MKC-V) (Packaged Foods) reported for 2026 q1:

- Revenue +20.6% YoY (vs +11.5% in previous quarter and historical rate +4.4%)
- EBITDA +25.4% YoY (vs -15.0% in previous quarter and historical rate +7.2%)
- EBITDA margin 18.1% increased compared to 17.4% same period last year
- Net Debt decreased by $144 mln over the past reporting period (0.9% of market cap)
- FCF (LTM) +$0.1 bln (positive), 0.6% of market cap
- EV/EBITDA multiple is 16.1x compared to historical level (75th percentile) of 20.1x
- EV/Sales multiple is 2.9x

2026-09-14
#reports #MKC

[McCormick](https://eninvs.com/all.php?name=MKC) (Spices and food additives manufacturer) reported for [2026 q1](https://eninvs.com/press_release.php?ticker=MKC&q=2026 q1&id=958729)
(2026-01-22, Before Market Open):

- Revenue +20.6% YoY (vs +11.5% in previous quarter and historical rate +4.4%)
- EBITDA +25.4% YoY (vs -15.0% in previous quarter and historical rate +6.9%)
- EBITDA margin 18.1% increased compared to 17.4% same period last year
- Net Debt decreased by $144 mln over the past reporting period (1.0% of market cap)
- FCF (LTM) +$0.1 bln (positive), 0.8% of market cap
- EV/EBITDA multiple is 14.4x compared to historical level (75th percentile) of 19.1x
- EV/Sales multiple is 2.6x

At the opening of the session the share price went down -4.9%
2026-09-14
#reports #MHO

[M/I Homes](https://eninvs.com/all.php?name=MHO) (Construction company) reported for 2026 q1
(2026-04-22, Before Market Open):

- Revenue +8.9% YoY (vs -23.6% in previous quarter and historical rate +0.8%)
- EBITDA -28.4% YoY (vs -47.9% in previous quarter and historical rate -7.4%)
- EBITDA margin 9.5% decreased compared to 14.4% same period last year
- EV/EBITDA multiple is 8x compared to historical level (75th percentile) of 5.9x
- EV/Sales multiple is 0.9x

2026-09-14
#reports #MHK

[Mohawk Industries](https://eninvs.com/all.php?name=MHK) (Floor covering manufacturer) reported for 2026 q1
(2026-04-30, After Market Close):

- Revenue +6.7% YoY (vs +8.0% in previous quarter and historical rate -0.7%)
- EBITDA +20.1% YoY (vs +19.5% in previous quarter and historical rate +4.3%)
- EBITDA margin 13.8% increased compared to 12.3% same period last year
- Net Debt decreased by $142 mln over the past reporting period (1.8% of market cap)
- FCF (LTM) +$0.6 bln (positive), 7.1% of market cap
- EV/EBITDA multiple is 7.6x compared to historical level (75th percentile) of 28.2x
- EV/Sales multiple is 0.9x

2026-09-14
#reports #MGRC

[McGrath](https://eninvs.com/all.php?name=MGRC) (Modular office supplier) reported for 2026 q1
(2026-02-25, After Market Close):

- Revenue +13.3% YoY (vs -18.4% in previous quarter and historical rate +7.1%)
- EBITDA +13.9% YoY (vs -21.1% in previous quarter and historical rate +38.0%)
- EBITDA margin 37.1% increased compared to 36.9% same period last year
- EV/EBITDA multiple is 8.1x compared to historical level (75th percentile) of 9.1x
- EV/Sales multiple is 3x

2026-09-14
#reports #MGPI

[MGP Ingredients](https://eninvs.com/all.php?name=MGPI) (Liquor manufacturer) reported for 2026 q1
(2026-02-25, Before Market Open):

- Revenue -14.5% YoY (vs -13.1% in previous quarter and historical rate -14.0%)
- EBITDA -7.7% YoY (vs -3440.0% in previous quarter and historical rate -45.3%)
- EBITDA margin 19.4% increased compared to 17.9% same period last year
- EV/Sales multiple is 1.1x

2026-09-14
#reports #MGNX

[MacroGenics](https://eninvs.com/all.php?name=MGNX) (Biotechnology) reported for 2026 q1
(2026-03-09, After Market Close):

- Revenue -70.3% YoY (vs +90.9% in previous quarter and historical rate +54.2%)
- EBITDA -122.4% YoY (vs -3300.0% in previous quarter and historical rate +23.1%)
- EBITDA margin -39.4% decreased compared to 52.3% same period last year
- EV/Sales multiple is 0.4x

2026-09-14
#reports #MEG

[Montrose Environmental Group](https://eninvs.com/all.php?name=MEG) (Waste Management) reported for 2026 q1
(2026-02-25, After Market Close):

- Revenue -20.4% YoY (vs -5.1% in previous quarter and historical rate +12.4%)
- EBITDA -32.1% YoY (vs +133.3% in previous quarter and historical rate +61.1%)
- EBITDA margin 10.2% decreased compared to 11.9% same period last year
- Net Debt increased by $25 mln over the past reporting period (3.0% of market cap)
- FCF (LTM) +$1 bln (positive), 120.4% of market cap
- EV/EBITDA multiple is 20x compared to historical level (75th percentile) of 147.6x
- EV/Sales multiple is 1.5x

2026-09-14
#reports #MEDP

[Medpace](https://eninvs.com/all.php?name=MEDP) (Medical device developer) reported for 2026 q1
(2026-04-22, After Market Close):

- Revenue +17.2% YoY (vs +26.5% in previous quarter and historical rate +18.8%)
- EBITDA +15.8% YoY (vs +23.3% in previous quarter and historical rate +21.1%)
- EBITDA margin 21.8% decreased compared to 22.1% same period last year
- EV/EBITDA multiple is 26.9x compared to historical level (75th percentile) of 31.7x
- EV/Sales multiple is 5.8x